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Abstract
Hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC) development. Hepatitis B virus
X protein (HBx) is known to play a key role in the development of hepatocellular carcinoma (HCC). Several cellular proteins
have been reported to be over-expressed in HBV-associated HCC tissues, but their role in the HBV-mediated oncogenesis
remains largely unknown. Here, we explored the effect of the over-expressed cellular protein, a ribosomal protein S3a
(RPS3a), on the HBx-induced NF-kB signaling as a critical step for HCC development. The enhancement of HBx-induced NF-
kB signaling by RPS3a was investigated by its ability to translocate NF-kB (p65) into the nucleus and the knock-down
analysis of RPS3a. Notably, further study revealed that the enhancement of NF-kB by RPS3a is mediated by its novel
chaperoning activity toward physiological HBx. The over-expression of RPS3a significantly increased the solubility of highly
aggregation-prone HBx. This chaperoning function of RPS3a for HBx is closely correlated with the enhanced NF-kB activity
by RPS3a. In addition, the mutational study of RPS3a showed that its N-terminal domain (1–50 amino acids) is important for
the chaperoning function and interaction with HBx. The results suggest that RPS3a, via extra-ribosomal chaperoning
function for HBx, contributes to virally induced oncogenesis by enhancing HBx-induced NF-kB signaling pathway.
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Introduction
Chronic infection of hepatitis B virus (HBV) is one of the major
causes of liver cirrhosis and hepatocellular carcinoma (HCC)
development [1,2]. The hepatitis B virus X protein (HBx) is a key
factor in HCC development during HBV infection [3,4] and is
detected in the majority of HBV-related HCC patients’ tissues [5].
A number of studies have shown that HBx promotes cell survival
and stimulates signaling pathways including Ras/MAPK cascades,
Wnt/b-catenin signaling and PI-3 kinase/Akt pathways, which are
closely related with tumorigenesis [3,4]. These upstream signaling
changes by HBx ultimately lead to the transactivation of
transcription factors such as NF-kB, which influence the cell
proliferation and eventually cancer development [3,6–11].
Recently, extensive studies on differential over-expression gene
profiles in HBV-induced HCC tissues were performed [12,13].
Interestingly, among those over-expressed genes, a number of
ribosomal subunit components (RPS20, RPL27a, RPLP0, RPL8,
RPL31, RPL37a, RPS24, RPS27a, RPL21, RPL35a, RPS8,
RPS37a, RPS3a, RPL36a) were identified [13]. The mRNA levels
of ribosomal subunits in HBV-induced HCC tissues were
5.7,20.5-fold higher as compared with the non-tumor normal
tissues. Among them, RPL36a was reported to be associated with
cellular proliferation in HCC [14]. RPL26 regulates the
translation and induction of p53 after DNA damage [15]. These
studies suggest that such ribosomal proteins are involved in cell
transformation rather than their classical role in protein synthesis.
Still, the role of the over-expressed ribosomal proteins in the HBV-
associated HCC and their relationship with viral proteins remains
largely unknown.
Among the over-expressed genes, ribosomal protein S3a
(RPS3a) exhibited 5.7 fold higher expression in HBV-induced
HCC patient tissues [13]. RPS3a, a component of the ribosomal
small subunit (40S) [16], shows high sequence homology in
mammalian cells and is localized in both the nucleus and
cytoplasm [17]. RPS3a also has multiple biological functions
unrelated with the ribosome. Previously known as Fte-1 (v-fos
transformation effector gene), RPS3a is an inducing factor for
oncogenic cellular transformation of Rat-1 cells by v-fos [18,19]. In
addition, RPS3a is highly expressed in most tumors including
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though the over-expression of RPS3a alone does not directly
induce cell transformation, RPS3a is closely related with abnormal
cell proliferation and transformation via extra-ribosomal activity
[18,26,27]. Importantly, it is reported that Epstein-Barr virus
(EBV)-induced B cell transformation leads to the up-regulation of
RPS3a. Furthermore, EBV-encoded nuclear antigen, EBNA-5 is
reported to bind RPS3a, suggesting a role for EBV-induced B cell
transformation [17]. On the other hand, RPS3a has also been
described as a regulator of apoptosis and transcription factors [27–
29]. RPS3a interacts with a transcription factor, GADD153, and
modulates erythropoiesis [30]. To date, a number of studies have
shown that RPS3a is associated with cell proliferation, differen-
tiation and tumor formation. However, there is no report on the
underlying mechanism for the multi-functional roles of RPS3a.
Here, we explored the possibility that RPS3a can enhance the
HBV-induced tumorigenesis by interacting with the viral onco-
genic HBx protein. Of note, HBx is highly aggregation-prone and
is expressed as punctate form in eukaryotic cells [31–34] and as
insoluble inclusion bodies in E. coli [35–37]. The highly
aggregation-prone tendency of HBx suggests that there might be
some cellular factors that assist the maintenance of HBx solubility
for its function. Consistent with this idea, molecular chaperones
have known to be involved in cancer development by stabilizing
oncogenic proteins [38–40]. In addition, it has recently been
reported that soluble macromolecules such as ribosomal proteins
and RNA can function as chaperones [41–45]. Thus, we, for the
first time, investigated whether RPS3a has a novel chaperoning
activity for viral oncoprotein HBx. The present study will give new
insights into the role of cellular proteins over-expressed in HBV-
associated HCC.
Results
RPS3a enhances the HBx-induced NF-kB signaling
The profiles of the cellular proteins that are over-expressed in
the HBV-associated HCC tissues have been reported [13].
Interestingly, many of these were ribosomal proteins. HBx has
been well established to activate the transcription factor NF-kB
(1.5,2-fold) through regulation of cancer-related signaling
pathways [3,8–11]. Therefore, we investigated whether the over-
expressed cellular proteins in the HBV-related HCC tissues can
influence the oncogenic activity of HBx. For this purpose, we
initially selected and cloned 18 over-expressed cellular genes in the
HBV-associated HCC tissues, most of which are ribosomal
proteins. After the co-tranfections of the cloned genes with HBx,
their effects on the HBx-mediated NF-kB activation were tested
using the luciferase reporter system. Through the first screening
(data not shown), 9 genes were selected for further study. Among
them, as shown in Figure 1A, seven genes (RPL27a, RPL8,
RPS24, RPS27a, RPL21, RPL35a and RPS3a) out of 9
significantly upregulated the HBx-induced NF-kB activity in
Huh7 cells. In particular, RPS3a was observed to enhance the
HBx-induced NF-kB activity most efficiently. This observation
was more prominent in HepG2 cells (Figure 1B).
To verify the enhancing ability of RPS3a on the HBx-induced
NF-kB signaling directly, we analyzed the nuclear translocation of
NF-kB subunits using NF-kB ELISA method and the electropho-
retic mobility shift assay (EMSA) as described in Materials and
methods. The nuclear NF-kB ELISA showed that the expression
of RPS3a itself alone did not affect the NF-kB activity, whereas in
the presence of HBx, RPS3a synergistically enhanced the NF-kB
activity. However, the over-expression of RPS3a did not affect the
total level of HBx (Figure 1C). The nuclear translocation of p65
was further confirmed by western blot analysis after co-
transfection of HBx and RPS3a. The coexpression of HBx and
RPS3a significantly promoted the nuclear localization of p65,
whereas the total amount of p65 in cytoplasm was slightly
decreased based on the ratio of p65/tubulin (Figure 1D). Finally,
we performed the EMSA to verify the enhancing ability of RPS3a.
The data clearly show that RPS3a hyperactivates the HBx-
induced NF-kB signaling (Figure 1E). The overall results of the
luciferase reporter assay, nuclear translocation of p65 and EMSA
demonstrate that RPS3a over-expressed in HBV-associated HCC
tissues enhances the HBx-induced NF-kB signaling in liver cells.
RPS3a is over-expressed in HBV-associated HCC tissues
Because the previous profile report of over-expressed proteins in
the HBV-associated HCC was monitored mainly using Northern
blot analysis [13], it is further necessary to investigate the over-
expressed protein levels in the HBV-associated HCC tissues. First,
we compared the relative mRNA levels of RPS3a between tumor
and non-tumor regions in the tissues from three HBV-associated
HCC patients (IBR approved), using semi-quantitative reverse
transcription PCR. Consistent with the previous results, the
RPS3a expression is significantly higher in tumor regions of HBV-
associated HCC tissues than in peripheral non-tumor regions
(Figure 2A and 2B). To further confirm the levels of RPS3a
protein expression in tissues, we produced recombinant RPS3a in
E. coli, and generated the anti-RPS3a antibody in rabbits. The
specificity of anti-RPS3a was confirmed using knock-down and
over-expression systems (Figure 2D). Immunohistochemical anal-
ysis of 20 cases of HBV-positive HCC tissues, paring non-tumor
and tumor tissues was carried out using anti-RPS3a antibody. The
70% (14 cases) of HBV-positive HCC tissues showed considerably
over-expression of RPS3a in tumor regions compared with the
corresponding peripheral non-tumor regions (Table 1). The
representative immunohistochemistry data show that the endog-
enous level of RPS3a protein is significantly higher in the tumor
regions of HBV-associated HCC than in non-tumor regions
(Figure 2C).
Over-expression of ribosomal proteins influence the
expression patterns of HBx
To understand how the over-expressed ribosomal proteins in
HCC tissues can influence the HBx-induced NF-kB activity, we
Figure 1. RPS3a enhances the HBx-induced NF-kB Signaling. (A–B) Relative NF-kB activity in Huh7 and HepG2 liver cells after co-transfection
of pNF-kB-Luc(0.25 mg), pEGFP(0.4 mg) (control plasmid) and the indicated plasmid(0.4 mg) with/without pEG-HBx(0.4 mg). (C) ELISA of NF-kB
activation in nucleus. Using nuclear extracts (4 mg), the binding between activated NF-kB subunit in nucleus and plate-bound NF-kB consensus DNA
oligomer was measured by chemiluminescence (left). Free unbound NF-kB consensus DNA oligomer was used as a competitor. Total expression
levels of HBx and RPS3a in whole cell lysate (WCL) were determined by indicated antibodies (right). (D) Western blot analysis of p65 translocation in
Huh7 cells. Lamin A/C and a-tubulin were used for loading controls of nuclear and cytoplasmic fractions, respectively. The loading amount in
cytoplasmic fractions is 5-fold dilution than that of the nuclear fractions. (E) Electrophoretic Mobility Shift Assay (EMSA). Separated nuclear extracts
(3 mg) were subjected to in vitro binding with [P
32]-labeled NF-kB consensus DNA oligomer probe. pEGFP vector was used as control vector. As a cold
competitor, excess (30-fold) non-labeled NF-kB consensus oligomer was used. Relative binding intensity was calculated by using densitometry.
doi:10.1371/journal.pone.0022258.g001
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fusion protein in Huh7 cells after co-transfection with ribosomal
proteins. Previous studies have demonstrated that the expression
pattern of HBx-GFP fusion protein is largely punctate with
granule-like insoluble aggregates in the cytoplasm [32]. The
typical pattern of HBx-GFP expression is shown in Figure 3A.
Interestingly, the over-expression of ribosomal proteins did not
alter the total expression level of HBx-GFP (Figure 3D), but
influenced the expression pattern of HBx-GFP protein (Figure 3B).
Among the ribosomal proteins, RPS3a resulted in a dramatic
decrease in its punctate expression when co-transfected with HBx-
GFP plasmid. The percentage of cells showing punctate expression
was about 30% when RPS3a was co-transfected, whereas that in
control pcDNA3.1 transfection was about 70% (Figure 3C). We
found that the reduction of punctate expression was correlated
with the enhanced activity of HBx-induced NF-kB signaling
(Figure 1A). These findings imply that RPS3a is associated with
the soluble expression of HBx in a functional form, which is also
relevant to HBx activity such as NF-kB signaling.
RPS3a enhances the HBx-induced NF-kB signaling via its
chaperoning activity
To elucidate the role of RPS3a in more detail, we assessed the
effects of RPS3a on both HBx-induced signaling and the soluble
expression of HBx. As shown in Figure 4A and 4B, the NF-kB
activity and the soluble expression of HBx were significantly
enhanced in proportion to RPS3a, whereas the total expression
levels of HBx were constant (Figure 4A). Consistent with NF-kB
activity (Figure 4A), the punctate expression of HBx was also
greatly decreased in a RPS3a dose-dependent manner (Figure 4B
and 4C). To show that RPS3a enhances the soluble expression of
HBx in cytoplasm, we measured the amount of soluble HBx in the
cytoplasmic fraction by both immunoprecipitation and western
blot analysis after co-transfection with RPS3a. The immunopre-
cipotation result clearly showed that the soluble expression of HBx
was increased by RPS3a in a dose-dependent manner (Figure 4D,
right), whereas the total expression level of HBx-GFP was not
changed (Figure 4D, left). Furthermore, we observed a similar
result by direct western blot analysis of soluble fraction and whole
cell lysate obtained after co-transfection of RPS3a and HBx-HA
(Figure 4E). However, the over-expression of another ribosomal
subunit that did not affect the HBx-induced NF-kB activation
(Figure 1A), RPS20, did not increase the soluble expression of
HBx (data not shown). The results suggest that RPS3a affects the
solubility of HBx rather than its stability.
To find more direct evidence, we investigated a solubility-
enhancing ability of RPS3a for HBx using the E. coli expression
system [45,46]. The expression of RPS3a-His and HBx-HA were
controlled by L-arabinose and IPTG, respectively. Expression of
HBx alone resulted in almost insoluble product (Soluble fraction:
4.9%); however, upon coexpression with RPS3a, the soluble
fraction of HBx protein greatly increased to 39% (Figure 4F, left).
As the control experiments, we coexpressed the RPS20 or EGFP
with HBx and observed no increase of soluble expression of HBx
(Figure 4F, right). These data demonstrate that this phenomenon
is not restricted to mammalian cells, suggesting that the chaperone
function of RPS3a on HBx is provided irrespective of the cellular
environment. Taken together, these results suggest that the
chaperoning effect of RPS3a on HBx is likely responsible for the
increased functional activity of HBx.
Knock-down of RPS3a abolishes the RPS3a-mediated
NF-kB enhancement by HBx
To further investigate the effect of RPS3a on HBx-mediated
NF-kB signaling, we performed the knock-down experiment using
RNA interference. We designed the siRNAs against RPS3a and
found that the RPS3a expression was greatly decreased by siRNA1
and 2 (Figure 5A and 5B, left). The treatment of RPS3a siRNAs
did not affect the total expression level of HBx and p65 (Figure 5B,
right). The treatment with siRNA1 or 2 under RPS3a and HBx
coexpression completely abolished the RPS3a-mediated NF-kB
enhancement, whereas the control siRNA had no effect
Figure 2. Expression of RPS3a in HBV-associated hepatocellular carcinoma tissues. (A) Detection of endogenous RPS3a mRNA levels in
the tumor and non-tumor regions of HBV-associated HCC tissues. Total RNA was extracted from tumor or non-tumor tissues of three HBV-caused HCC
patients. Using total RNA extracts (2 mg) and oligo dT primer, cDNA was synthesized. N and T represent the non-tumor tissues and tumor tissues,
respectively. (B) Relative expression ratio of RPS3a mRNA between the tumor and non-tumor tissues of HBV-associated HCC. Data were calculated by
three independent experiments (* P,0.05 and ** P,0.001). Data represent the intensity ratio of RPS3a band after normalization to GAPDH in the Bio-
1D image analysis software. (C) Representative immunohistochemistry data of endogenous RPS3a protein expression in the HBV-associated HCC
tissues. The difference of RPS3a expression between non-tumor and tumor tissues was determined by visual inspection under microscope
(magnification6400) and assigned on the top of the panels. See Table 1 for full information. (D) Generation and validation of human RPS3a antibody.
Human RPS3a protein was produced in E. coli and the rabbit antibody was generated. The specificity of the generated antibody was validated by
knock-down and over-expression of RPS3a in Huh7 cells. Huh7 cells were harvested at 72 hr after transfection.
doi:10.1371/journal.pone.0022258.g002
Table 1. Expression level of RPS3a and information of tissue
samples.
Tissue No. Sex Age HBV HCV RPS3a expression
A7 F 51 + 2 NT%T
B3 M 43 + N.D
B9 M 42 + 2
D1 M 60 + 2
E3 M 49 + 2
F9 M 53 + 2
G3 M 61 + 2
H3 M 50 + 2
B5 M 51 ++NT,T
B7 M 59 + 2
E1 F 40 + 2
E5 F 63 + 2
E11 M 37 + 2
H11 M 51 + N.D
C1 F 65 + 2 NT<T
D11 M 59 + 2
F5 M 43 + 2
G5 M 56 + 2
G11 M 54 + 2
H9 M 69 + N.D
N.D: Not Deterimed; NT: Non-Tumor; T: Tumor.
doi:10.1371/journal.pone.0022258.t001
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GFP and HBx-GFP expression in liver cells. Huh7 cells were transfected with 2 mg of pEGFP or pEG-HBx-GFP plasmid in 6-well plates. After 36 hr, the
expression pattern of each protein was examined by fluorescence microscopy (magnification6400). (B) Reduction of punctate expression of HBx-GFP
by ribosomal proteins. pEG-HBx-GFP (2 mg) and indicated plasmids(2 mg) were coexpressed in Huh7 cells. pEGFP or pcDNA3.1 plasmids were used as
control (magnification6200). (C) Number of cells showing punctate expression was counted under fluorescence microscopy. Ratios of punctate cells
were calculated and presented by bar graph. (D) Total expression levels of HBx-GFP in whole cell lysate (WCL) were determined by anti-GFP antibody
after co-transfection of indicated ribosomal subunits and pEG-HBx-GFP.
doi:10.1371/journal.pone.0022258.g003
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NF-kB activity by siRNAs. The treatment of siRNA decreased the
RPS3a-mediated NF-kB enhancement by HBx commensurate to
the basal level (GFP alone), which was much less than that of HBx
alone. These data imply that the endogenous RPS3a is associated
with the HBx-induced NF-kB activation. To confirm the
involvement of endogenous RPS3a in HBx-mediated NF-kB
activation, we determined the HBx-induced NF-kB activity under
the knock-down of endogenous RPS3a by siRNA. The knock-
down of endogenous RPS3a was confirmed as described in
Figure 2D. Under this condition, the NF-kB activity was decreased
blow the basal level (Figure 5D), confirming that the endogenous
RPS3a has an important role for the HBx-induced NF-kB
activation.
In particular, because the expression of RPS3a is abundant in
HCC tissues (Table 1) [13], the effect of over-expression of RPS3a
in HCC cell lines is expected to be marginal due to saturation in
the cytoplasm. Therefore, the results from knock-down of RPS3a
by siRNA would provide more compelling evidence than the over-
expression.
Identification of the domain of RPS3a necessary for
chaperoning function on HBx
To identify the domain of RPS3a that is responsible for the
chaperoning activity on HBx, we generated several deletion
mutants of RPS3a as described in Figure 6A, and the expression of
these mutants was confirmed by western blot analysis (Figure 7D).
Using these deletion mutants, we performed the HBx-induced NF-
kB activation assay. All the N-terminal deletion mutants (M1 to
M3) significantly decreased the HBx-induced NF-kB hyperactiva-
tion, while the C-terminal deletion mutants (M4, M5) showed no
significant change in the NF-kB hyperactivation compared to the
wt RPS3a (Figure 6B).
Inaddition,theeffectofRPS3amutantsonthe solubleexpression
of HBx was analyzed using fluorescence microscopy. The N-
terminal deletion mutants lost the ability to solubilize the puntate
expression of HBx-GFP, in contrast with the C-terminal mutants
(M4, M5) (Figure 6C and 6D). These solubility-enhancing effects of
RPS3a mutants are well correlated with their HBx-induced NF-kB
hyperactivation (Figure 6B). These findings demonstrate that the N-
terminal domain of RPS3a (amino acids 1–50) is responsible for the
RPS3a-mediated chaperoning function on HBx.
RPS3a interacts with HBx via its N-terminal domain
Generally, the chaperoning function of a protein is mediated by
the protein-protein interaction between the molecular chaperone
and target protein. Therefore, we investigated whether the
chaperoning activity of RPS3a is mediated by the physical
interaction between RPS3a and HBx. We performed the co-
immunoprecipitation assay after co-transfection of RPS3a-flag and
HBx-GFP in Huh7 cells. The data clearly show that RPS3a
interacts with HBx in the cytoplasm (Figure 7A). To further verify
the interaction between RPS3a and HBx, we conducted the co-
immunoprecipitation assay using RPS3a-flag and HBx-HA
constructs in HepG2 cells; these assays also confirmed that RPS3a
interacts with HBx in cytoplasm (Figure 7B). In addition, to verify
the association between RPS3a and HBx in physiologically
relevant environment, we examined whether the endogenous
RPS3a can interact with HBx. We confirmed that the endogenous
RPS3a interacts with HBx (Figure 7C), supporting the result of
Figure 5D.
The above results in Figure 6 demonstrate that the N-terminal
domain of RPS3a is responsible for the chaperoning function on
HBx, allowing us to predict that this domain is necessary for
RPS3a binding with HBx. The RPS3a deletion mutants
(Figure 6A) were subjected to co-immunoprecipitation assay after
co-transfection with HBx. The expression levels of the deletion
mutants in Huh7 cells were similar; however, only mutants M4
and M5 were bound with HBx (Figure 7D). These data
demonstrate that the N-terminal 50 amino acids are responsible
for RPS3a binding with HBx. The results are well correlated with
previous data of the chaperone activity of RPS3a on HBx
(Figure 6). Taken together, the N-terminal 50 amino acids of
RPS3a are responsible for the chaperoning activity via binding
with HBx.
Finally, we confirmed the interaction between RPS3a and HBx
using co-localization assays (Figure 7E). As predicted, RPS3a was
co-localized with HBx. Notably, the weak expression of RPS3a
(blue triangles) is correlated with punctate expression of HBx,
whereas the cells over-expressing RPS3a show soluble expression
of HBx (white triangles).
RPS3a enhances HBx-induced NF-kB signaling in the
context of a replication-competent full HBV genome via
its chaperoning function for HBx
The evidence so far of RPS3a-mediated upregulation of HBx-
induced NF-kB signaling through its chaperoning activity, is based
on HBx over-expression system driven by a non-viral promoter.
Therefore, to investigate whether the effects of RPS3a on HBx
also work under more physiological condition, we used a
replication-competent full wt HBV genome [wt HBV 1.3mer]
and HBx-deficient HBV genome [HBV 1.3mer(X-)]. We also
Figure 4. RPS3a enhances HBx-induced NF-kB signaling via its chaperoning activity. (A) Dose-dependent activation of NF-kB by RPS3a.
The pEG-HBx (0.4 mg) was co-transfected with increasing amounts of RPS3a and pNF-kB-Luc (0.25 mg) in Huh7 cells. Total DNA amounts (1.5 mg) were
adjusted using pEGFP in 12-well plates. Total expression levels of RPS3a and HBx in whole cell lysate (WCL) were determined by anti-flag and anti-HA
antibodies, respectively (right). (B–C) Decrease of punctate expression of HBx-GFP by RPS3 in a dose-dependent manner. Huh7 cells were co-
transfected with pEG-HBx-GFP (2 ug) and increasing amounts of RPS3a. The amount of total transfected DNA was normalized using pcDNA3.1.
Representative patterns of HBx-GFP expression at 36 hr post-transfection are presented in panel B (magnification 6200). The number of cells
showing punctate expression of HBx-GFP was counted under fluorescence microscopy and the ratio of punctate cells was calculated in panel C. (D)
Soluble expression of HBx-GFP in cytoplasm by RPS3a. The pEG-HBx-GFP (1.5 mg) was co-transfected with increasing amounts of pcD-RPS3a-flag. The
pEGFP(0.5 mg) was transfected as a control for transfection and detection by GFP antibody. At 96 hr post-transfection, cells were lysed and
cytoplasmic soluble fraction was immunoprecipitated with anti-GFP antibody (right). As a control, the whole cell lysate (WCL) before centrifugation
was analyzed for the total expression of HBx-GFP (left). Note the expression ratio of HBx-GFP/GFP. (E) Soluble expression of HBx in cytoplasm by
RPS3a. After co-transfection of pcD-HBx-HA and pcD-RPS3a-flag, the whole cell lysate (WSL) and the soluble fraction (supernatant of WCL after
centrifugation) were analyzed by western blot analysis. (F) RPS3a enhances the soluble expression of HBx in E. coli expression system. E. coli cells were
co-transformed with pT7-HBx-HA and pBad-RPS3a-His plasmids. After culture and co-induction by IPTG and L-arabinose, total cell extracts were
obtained by sonication and divided into fractions using centrifugation at 12000 rpm (T, S and P represent total cell extracts, supernatant, and pellet
fraction, respectively). The expression pattern of HBx was analyzed by western blot. Soluble expression was calculated by densitometry. As random
protein controls, pBad-RPS20-His, another ribosomal subunit and pBad-EGFP-His plasmids were used for co-transformation with pT7-HBx-HA in E. coli
cells. Both RPS20 and EGFP were detected by anti-penta His antibody (Qiagen).
doi:10.1371/journal.pone.0022258.g004
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affect the total levels of viral proteins (HBx, surface and core)
which are expressed by own viral promoters (Figure 8C and 8D).
The NF-kB luciferase assay showed that RPS3a exerts no effect on
HBV 1.3mer(X-); however, RPS3a hyperactivated the NF-kB
activity when co-transfected with wt HBV 1.3mer (Figure 8A).
This result demonstrates that the enhanced NF-kB signal is also
HBx-dependent in full HBV genome system. As in Figure 5C, the
RPS3a-mediated NF-kB hyperactivation by genome-driven HBx
was also abolished by siRNA against RPS3a. When endogenous
RPS3a was depleted by siRNA, the HBV-meditated NF-kB
activation was also dramatically decreased under the basal level
(Figure 8B).
To investigate whether the over-expressed RPS3a enhances the
soluble expression of genome-driven HBx, we employed the
transient transfection of HBV1.3mer and HBV-stable cell line,
HepG2.2.15 systems. The results also clearly show that the RPS3a
enhances the soluble expression of HBx that is expressed by HBV
genome. This phenomenon was more prominent in HepG2.2.15
cells (Figure 8E). Taken together; these data suggest that over-
expressed RPS3a in HCC can enhance the HBx-induced NF-kB
signaling in the natural course of HBV infection through the
increase of functional activity of HBx.
Finally, we also examined if HBV or HBx could affect the
expression of RPS3a. Neither HBV nor HBx (Figure 7C) affects
the expression level of RPS3a in itself (data not shown), suggesting
that the over-expression of RPS3a in HBV-associated HCC tissues
is HBV-independent.
Discussion
In the present study, we addressed the role of RPS3a, a protein
over-expressed in the HBV-associated HCC, on the HBx-induced
NF-kB activation as a critical factor for oncogenesis. Molecular
studies revealed that RPS3a has a novel chaperoning activity and
provides its chaperoning function to the highly aggregation-prone
HBx. Although many of the host proteins have been well known to
be over-expressed in the virus-caused cancers, their role for the
viral pathogenesis remains unsolved. Our finding on the interplay
between RPS3a and HBx gives some clues to the role of over-
expressed host factors, especially in the HBV-associated HCC.
Here, the over-expressed proteins in the HBV-caused HCC
[13,20] were investigated to determine whether they have some
relationship with the HBV pathogenic effects, especially the HBx-
caused HCC development. Interestingly, among the over-
expressed proteins, many of them were ribosomal proteins.
Although the expression of ribosomal proteins would be expected
to be higher in the rapidly growing tumors for ribosomal assembly
and protein synthesis, the stoichiometric ratio between ribosomal
proteins was unbalanced in tumors [13]. This finding indicates
that the over-expressed ribosomal proteins can be involved in
other biological roles besides protein synthesis.
Most of the over-expressed ribosomal proteins activated the
HBx-induced NF-kB signal; among them, RPS3a hyperactivated
the HBx transactivity in the hepatoma cell line (Figure 1). And we
showed that protein level of RPS3a is significantly higher in the
HBV-related HCC tissues as compared with non-tumor tissues
(Figure 2C). In addition, we found that NF-kB hyperactivation is
closely linked to the soluble expression of otherwise aggregation-
prone HBx (Figure 3, 4 and 8). Molecular studies have revealed
that the insoluble granule-like punctate form of HBx was
solubilized by interaction with the N-terminal domain of RPS3a
(Figure 6 and 7). Therefore, we suggest that RPS3a provides
chaperoning function to HBx preventing it from aggregation into
punctate form. This was confirmed in both liver cells (Figure 4D
and 4E) and the E. coli system (Figure 4F). In particular, RPS3a
also enhanced the soluble expression of genome-driven HBx
suggesting the physiological relevance of our finding (Figure 8E).
Of the interest, the soluble expression of genome-driven HBx in
HepG2.2.15 is very low, whereas the total expression is high. Until
now, there is no clear evidence that HBx forms aggregates during
HBV replication. Therefore, it is not clear whether the insoluble
HBx is cytoplasmic insoluble aggregates or associated with nucleus
or cytoplasmic organelles. However, our data clearly demonstrate
that RPS3a solublizes the HBx into cytoplasm. Although the
definite mechanism of RPS3a-mediated chaperoning effect and
the biological relevance of our studies to a true HBV infection
require further studies, it is likely that the solubility enhancement
of HBx by RPS3a could be eventually responsible for the increased
functional activity of HBx. The enhancement of HBx functional
activity by RPS3a may subsequently amplify the known HBx-
related oncogenic signaling pathways including NF-kB activation.
Interestingly, RPS3a has been associated with cell transforma-
tion, growth [18,26,27] and many cancers [20–25]. In particular,
RPS3a is associated with EBV, an oncogenic virus [17]. Similar to
HBx in our studies, EBNA-5, an EBV-encoded viral protein, binds
with RPS3a and induces RPS3a expression, suggesting a role of
RPS3a in EBV-induced tumorigenesis [17]. In this regard, the
binding between HBx and RPS3a may contribute to the
development and progression of HBV-induced HCC.
Many previous reports have shown that chaperones are
associated with cancer development. Generally, chaperones such
as HSP70 and HSP90, which are highly expressed under various
stress conditions such as heat shock, hypoxia and cancer cells,
stabilize abnormally folded or partially denatured proteins, and
intrinsically unstable cellular and viral oncoproteins that play a key
regulatory roles in signal transduction, cell survival, cancer
development and apoptosis [38–40]. As an example, HSP90 is
known as a molecular chaperone of numerous oncoproteins that
accelerates cancer development by stabilizing the structure and
function of those cellular factors, such as mutated p53, Bcr-Abl,
Akt, Raf-1, Hif-1a and SRC tyrosine kinase [39,40].
Recently, a potent extra-ribosomal chaperone activity of several
ribosomal proteins, commensurate to well known chaperone
(HSP90), was reported in E. coli [41]. In addition, over-expressed
ribosomal proteins also functioned as chaperones in Saccharomyces
cerevisiae [42]. Moreover, our recent reports have shown that
soluble macro-molecules can intrinsically provide chaperoning
function through interaction with aggregation-prone proteins [43–
45]. These studies support our findings that RPS3a enhances the
Figure 5. Knock-down of RPS3a abolishes RPS3a-mediated NF-kB enhancement by HBx. (A) A schematic representation of siRNA design
on RPS3a gene. (B) The effect of three siRNA candidates on RPS3a, HBx and endogenous p65 expression. Cells were co-transfected with pcD-RPS3a-
flag (or pcD-HBx-HA) and each RPS3a siRNA candidate (siRNA1, 2, 3), and harvested after 72 hr post-transfection. siRNAs against lamin, GFP, luciferase
(GL3) were used as control siRNAs. Expression levels of proteins were detected by indicated antibodies. (C) Effect of RPS3a knock-down on NF-kB
activity. The plasmids of pcD-RPS3a (0.4 mg), pEG-HBx (0.4 mg), and pNF-kB-Luc (0.25 mg) were co-transfected with the RPS3a siRNA1 or siRNA2.
Lamin siRNA was used as a control siRNA. (D) Effect of endogenous RPS3a on HBx-mediated NF-kB activation. NF-kB activity was determined at 30 hr
post co-transfection of pNF-kB-Luc and indicated plasmids with/without siRNAs in Huh7 cells. Note that knock-down of the endogenous RPS3a
lowered the HBx-induced NF-kB activity to the background level.
doi:10.1371/journal.pone.0022258.g005
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viral regulatory HBx protein via chaperoning activity.
RPS3a has been reported to be highly expressed in most tumors
including HCC [13,20], thyroid carcinoma [21], virus-associated
lymphoma [25], lung cancer [23], colorectal cancer [22] and
thymic tumor [24]. However, the biochemical roles of RPS3a in
these cancers have not been known yet. In this regard, RPS3a
might be another class of molecular chaperone acting on cancer-
related proteins including cellular and viral proteins. Here, we
propose that abnormally over-expressed RPS3a in HBV-associat-
ed HCC might allow the structurally unstable viral HBx protein to
gain the stability and functional activity by its chaperoning activity.
HBx, having acquired stability and solubility by RPS3a, can then
exert an effective viral oncogenic activity.
Our present results have many implications in HBV-associated
liver diseases. HBx, a multifunctional viral protein, has been
known to interact with a variety of cellular proteins involved in
control of cell cycle, induction of proto-oncogenes, transactivation
of key genes related to cell growth. Nevertheless, the extensive
studies on the chaperoning roles of those interacting proteins on
HBx have not been considered. Our results imply that HBx might
gain its stability against aggregation by interaction with those
cellular partners, which consequently lead to the HBx-related
various pathogenic effects during HBV infection. In addition,
HSP90 is already a potential anti-cancer drug target and
numerous small molecule inhibitors of HSP90, such as geldana-
mycin, have been developed and used in conjunction with other
anti-cancer drugs, for combinational therapies [40,47]. Similarly,
our study suggests that inhibition of cellular partners from
endowing the functional stability for HBx could be another target
for the prevention of HBV-associated liver diseases.
Materials and Methods
Plasmids construction
The details on HBx (subtype ayw) and HBx-GFP clones have
been described previously [32]. The expression plasmid for wild-
type HBx-HA was generated by PCR in pcDNA3.1 vector
(Invitrogen). The wild-type HBV 1.3mer and HBx-deficient HBV
1.3mer(X-) plasmids were kindly provided by Professor WS Ryu
(Yonsei University). The cDNAs of Hsp70p2, RPL27a, RPS20,
RPL8, RPS24, RPS27a, RPL21, RPL35a and RPS3a were
obtained from Korean UniGene Information (KUGI) and sub-
cloned into pcDNA3.1. Additionally, the wild-type, deletion
mutants (M1, M2, M3, M4, M5) of RPS3a-flag and RPS20-flag
were generated by PCR. For expression in E. coli, pGE-RPS3a-
His, pBad-RPS3a-His, pBad-RPS20-His, pBad-EGFP-His and
pT7-HBx-HA were constructed by PCR using NdeI and HindIII
restriction enzyme sites.
Reagents and Cell transfection
Antibody for the detection of GFP was purchased from
Clontech (Palo Alto, CA). Antibodies for a-tubulin was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA) and those for
lamin A/C and NF-kB p65 were obtained from Cell Signaling
(Danvers, MA). To detect the HBV surface, core and HBx
proteins, the anti-HBV surface antigen (abcam, MA, USA), anti-
HBV core (Dako, Denmark) and the polyclonal anti-HBx
(MYBiosource, CA, USA) antibodies were used, respectively.
The anti-Flag M2 monoclonal antibody, rabbit anti-HA, anti-b-
actin and secondary antibodies were obtained from Sigma (St.
Louis, MO). Alexa Fluor-568 secondary antibody was purchased
from Invitrogen (Carlsbad, CA). The human hepatoma cell lines
(Huh 7, HepG2 and HepG2.2.15 cell lines) were obtained from
the American Type Culture Collection (ATCC, Manassas, VA).
Huh7, HepG2 and HepG2.2.15 were maintained in DMEM
(Gibco BRL, Oregon, USA) supplemented with 10% heat-
inactivated FBS and 1% antibiotic-antimicotics (Gibco BRL,
Oregon, USA). Transient transfections (80%,90% cell con-
fluency) were performed using Lipofectamine2000 (Invitrogen,
Carlsbad, CA) or LT1 (Mirus, Madison, WI) according to the
manufacturer’s instruction.
Luciferase assay
Luciferase assays were performed for the detection of HBx or
HBV genome-mediated NF-kB activation. Approximately 4610
4
Huh7 and HepG2 cells were seeded into 12-well culture plates,
and transiently transfected with a DNA mixture containing
1.05 mg of plasmid (0.25 mg pNF-kB-Luc, 0.4 mg HBx or HBV
1.3mer, and 0.4 mg of test plasmids). To normalize the total
amount of transfection DNA, empty vector (pCMV) was used as
needed. Cells were harvested and lysed at 36 hr after transfection
(otherwise mentioned in Figure legends) and assayed for luciferase
activity using the Steady Glo-Luciferase system (Promega,
Madison, WI). Data were collected from the results of at least
five independent experiments. The statistical significance was
verified by statistical t-test analysis (P,0.05).
Western blot and immunoprecipitation assay
Western blot analyses and immunoprecipitation assays were
carried out as described previously [32]. Cells were lysed using
lysis buffer [25 mM Tris/HCl, 1% NP-40 (or 1% Triton X-100
for whole cell lysate), 0.5% protease inhibitor cocktail (Sigma,
St.Louis, MO), 150 mM NaCl, 2 mM KCl, pH 7.4]. For
immunoprecipitation, cells were lysed with 0.3 ml or 0.4 ml of
immunoprecipitation lysis buffer [25 mM Tris/HCl, 1% Triton
X-100 (or 0.5% NP-40), 0.5% protease inhibitor cocktail, 150 mM
Nacl, 2 mM KCl, pH 7.4]. The clarified total cell lysates were
incubated with primary antibodies for 24 hr at 4uC with gentle
inverting and then mixed with 10 ml of protein-A agarose (Roche,
Mannheim, Germany) followed by overnight incubation at 4uC.
After washing in PBS three times, the immune complex was mixed
with 56 SDS sample buffer. After blotting, membranes were
stripped with stripping buffer (Pierce, Rockford, IL) and reblotted.
Fluorescence analysis
To observe punctate expression of HBx, fluorescence analysis
was performed as previously described [32]. Huh7 cells were co-
transfected with pEGFP or pEG-HBx-GFP plasmid and test
plasmids. After 36 hr, the cells were analyzed by fluorescence
microscopy (magnification, 6200). For the co-localization assay,
RPS3a-flag and HBx-GFP plasmids were co-transfected in Huh7
Figure 6. The N-terminal domain of RPS3a is critical for NF-kB hyperactivation and the soluble expression of HBx. (A) Construction of
RPS3a deletion mutants. (B) The N-terminal domain of RPS3a is responsible for HBx-induced NF-kB activity. After co-transfection with wild-type or
deletion mutants of RPS3a (0.4 mg) and pEG-HBx (0.4 mg) in Huh7 cells, the relative NF-kB activity was measured. (C) The N-terminal region of RPS3a is
responsible for the punctate expression of HBx. After 36 hr co-transfection with pEG-HBx-GFP (2 mg) and wild-type or mutant RPS3a (2 mg), the
expression pattern of HBx-GFP protein was examined by fluorescence microscopy (magnification 6200). (D) Number of cells showing punctate
expression was counted under fluorescence microscopy. Ratio of punctate cells was calculated and presented by bar graph.
doi:10.1371/journal.pone.0022258.g006
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transfection, the cells were fixed with fixing solution (methanol/
formaldehyde=99:1). The cells were permeabilized with 0.2%
Triton X-100 for 30 min on ice. PBS containing 1% BSA was
used for blocking at room temperature for 1 hr and cells were
washed with PBS. The cells were incubated with anti-flag antibody
(1:50) overnight at 4uC. After washing, cells were incubated with
1:1000 diluted Alexa Fluor-568 goat secondary antibody for
40 min at room temperature. After 3 washes with PBS, DAPI
solution (1 mg/ml) was used to stain the nucleus. Cells were
mounted and examined under a fluorescence microscope
(magnification, 6200).
Generation of RPS3a antibody using recombinant protein
Rabbit polyclonal antibodies for detection of RPS3a were
generated using full-length recombinant human RPS3a proteins
expressed in E. coli. First, human RPS3a with 66His tag was cloned
in E. coli expression pGE vector, controlled by T7 promoter and
protein was over-expressed in BL21(DE3)pLysS E. coli strain
(Novagen). Recombinant RPS3a-His proteins were solubly ex-
pressed in E. coli. For purification of recombinant RPS3a-His
protein from E. coli extracts, one-step Ni-affinity chromatography
was performed twice using AKTA Prime FPLC (GE Healthcare).
Rabbits were immunized with the purified recombinant RPS3a-His
proteins, and the 1
st and 2
nd boosts were administered at 4 weeks
and 6 weeks after the primary immunization. The polyclonal anti-
RPS3a antibodies were purified from serum using protein A beads.
Antibody affinity for RPS3a protein was tested by ELISA and
western blot analysis. The generated rabbit polyclonal anti-RPS3a
antibodies could detect the endogenous human and mouse RPS3a.
Immunohistochemistry
The 20 pairs of HBV-positive human liver tissues consisting of
non-tumor and tumor regions were obtained from ISU Abxis
(Seoul, Korea). The information on liver tissues is summarized in
Table 1. Liver sections were rehydrated using graded alcohols. For
antigen retrieval, pretreatment in citrate buffer (pH 6.0) was
performed. Endogenous peroxidase was inactivated with methanol
containing 3% H2O2. After blocking, the tissue slide was
incubated overnight with rabbit polyclonal anti-RPS3a antibody
(generated in our lab) in a wet chamber at 4uC. After washing with
PBS, the tissue slide was incubated with goat anti-rabbit antibody
(EnVision
TM Kits, DAKO, Denmark) at room temperature. The
slides were developed using 3,39-diaminobenzidine tetrahy-
drochloride chromogen solution (DAKO). The slides were then
counter-stained with hematoxylin.
RT-PCR and RNA interference experiment
Total RNAs were isolated using Trizol solution (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol. Using
2 mg of total RNA and oligo dT primer, first-strand cDNA was
synthesized by the Power cDNA synthesis kit (Intron Biotechnol-
ogy, Seoul, Korea). A mixture of 1 ml cDNA product, 0.5 mM
target specific primers (RPS3a, GAPDH), 0.5 U exTaq polymerase
(Takara, Shiga, Japan) and 0.25 mM dNTP were used for PCR
(24 cycles). The specific primers were as follows: RPS3a sense, 59-
GTC ACG CTC GAG ATG AGG ACC CAA GGA ACC-39 and
antisense, 59-GTC ACG AAG CTT TTA AAC AGA TTC TTG
GAC-39; GAPDH sense, 59-CGT CTT CAC CAC CAT GGA
GA-39 and antisense, 59-CGG CCA TCA CGC CAC AGT TT-
39. After resolving the products on 1.5% agarose gels, the relative
expression levels were estimated using Bio-1D image analysis
software (Vilber Lourmat).
For knock-down studies of RPS3a, siRNAs against RPS3a were
synthesized by Samchully Pharm (Seoul, Korea). Sense and
antisense RNA fragments were mixed with 56universal binding
buffer and incubated at 90uC for 2 min. For annealing, the
mixture was reincubated for 1 hr at 30uC. The details of siRNA
sequences are follows: RPS3a siRNA1 sense, 59-GUG CUA AAG
UUG AAC GAG C -39 and antisense, 59-GCU CGU UCA ACU
UUA GCA C -39; RPS3a siRNA2 sense, 59-GGA UCU UAC
CCG UGA CAA A -39 and antisense, 59-UUU GUC ACG GGU
AAG AUC C -39; RPS3a siRNA3 sense, 59-AGA UUG GUA
UGA UGU GAA A -39 and antisense, 59-UUU CAC AUC AUA
CCA AUC U -39; control siRNA lamin sense, 59-CUG GAC
UUC CAG AAG AAC ATT-39 and antisense, 59-UGU UCU
UCU GGA AGU CCA GTT-39; GL3 siRNA sense, 59-CUU
ACG CUG AGU ACU UCG ATT-39 and antisense, 59-UCG
AAG UAC UCA GCG UAA GTT-39; GFP siRNA sense, 59-
GUU CAG CGU GUC CGG CGA GTT-39 and antisense, 59-
CUC GCC GGA CAC GCU GAA CTT-39. Transfection of
siRNA was performed using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA). The effects of RPS3a siRNAs were verified by
western blotting.
Electrophoretic mobility shift assay (EMSA) and NF-kB
EMSA-ELISA analysis
At 18 hr post-transfection, cells were harvested and the nuclear
and cytoplasmic fractions were prepared using Nuclear and
Cytoplasmic Extraction Reagents (Pierce, Rockford, IL). The level
of p65 translocation into nucleus was measured by EMSA-ELISA
analysis (EZ-Detect Transcription Factor Kits for NF-kB p65,
Pierce, Rockford, IL) and EMSA assay. For EMSA-ELISA
analysis, the nuclear extracts (4 mg) were incubated with the
supplied plate and the level of p65 was determined by ELISA. For
EMSA, the nuclear extracts (3 mg) were pre-incubated with 2 mgo f
poly(dI-dC) for 10 min in total 20 ml reaction buffer [10 mM Tris-
Cl(pH 7.5), 100 mM Nacl, 1 mM EDTA, 0.5 mM DTT, 10%
glycerol]. After pre-incubation, the [
32P]-end-labeled dsDNA
oligonucleotide (NF-kB consensus oligonucleotide: 59-AGTT-
Figure 7. RPS3a interacts with HBx via its N-terminal domain and co-localizes in liver cells. (A) RPS3a physically interacts with HBx in liver
cells. pEG-HBx-GFP and pcD-RPS3a-flag were transfected in Huh7 cells. At 96 hr post-transfection, cell lysates were immunoprecipitated with anti-flag
antibody (left) and anti-GFP antibody (right). Western blot analysis was performed using indicated antibodies. After stripping, each membrane was
treated with anti-HBx antibody (left) and anti-flag antibody (right). As a positive control for identifying the RPS3a-flag band, immunoprecipitation was
performed with anti-flag followed by western blot using the same antibody. (B) Interaction of HBx with RPS3a in HepG2 cells without GFP-fusion. The
pcD-HBx-HA and pcD-RPS3a-flag were co-transfected in HepG2 cells and the immunoprecipitation and western blot were performed as indicated. (C)
Interaction of HBx with endogenous RPS3a in Huh7 cells. The pcD-HBx-HA was transfected in Huh7 cells and immunoprecipitation and western blot
were performed as indicated. (D) Identification of RPS3a binding domain critical for HBx interaction. Wild-type pcD-RPS3a-flag (2 mg) or pcD-mutants
RPS3a-flag (M1,M5) (2 mg) were co-transfected with pcD-HBx-HA (2 mg) in Huh7 cells. Aliquots of total lysates were used for western blot analysis
(lower panel). The remaining lysates were immunoprecipitated with anti-HA antibody and detected by anti-flag antibody. After stripping, the
membrane was reblotted by anti-HA antibody. (E) HBx and RPS3a co-localize in transfected liver cells. Huh7 cells were co-transfected with pEG-HBx-
GFP (2 mg) and pcD-RPS3a-flag (2 mg). After 24 hr, immunocytochemistry analysis was performed using anti-flag antibody. White and blue triangles
indicate the cells with high and low expression of RPS3a, respectively. Note that low expression of RPS3a is linked with punctate expression of HBx.
doi:10.1371/journal.pone.0022258.g007
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added and incubated for 15 min. After the binding reaction,
DNA-protein complex was analyzed by electrophoresis at room
temperature using 5% polyacrylamide gel containing 10% glycerol
and 16 TBE. Then, gels were dried and autoradiographed. For
the competition assay, unlabeled NF-kB oligonucleotide was
added and incubated for 25 min before treatment with [
32P]-
labeled probe. Each analysis was carried out at least 5 times.
Solubility enhancing experiment in E. coli system
For the induction of proteins in E. coli, the pT7-HBx-HA
(Kan+) and pBad-RPS3a-His(Amp+) clones, which were inducible
by IPTG and L-Arabinose, respectively, were constructed. Both
plasmids were co-transformed in BL21(DE3)pLysS E. coli strains
with LB media containing chloramphenicol, kanamycin and
ampicillin. The RPS3a-His and HBx-HA proteins were induced
at 30uC by treatment with 0.2% L-Arabinose and 1 mM IPTG
(Sigma, St.Louis, MO), respectively. After induction, cells were
cultured for 3 hr at 20uC and harvested by centrifugation at
3000 rpm. Cells were lysed by sonication and divided into three
fractions [total lysate (T), supernatant (S), and pellet (P)] by
centrifugation. As the controls, pBad-RPS20-His(Amp+) or pBad-
EGFP-His(Amp+) were used for co-transformation with pT7-
HBx-HA (Kan+). Detailed solubility analysis was performed as
described previously [45,46]. The solubility of HBx-HA, i.e., the
relative ratio of (S)/(T), was estimated by Bio-1D image analysis
software (Vilber Lourmat).
Acknowledgments
We thank Dr. WS Ryu (Yonsei Univ.) for providing the wt HBV 1.3mer
and HBV 1.3mer(X-) plasmids, Dr. HJ Park (Ewha Womans University.)
for technical advice and providing pNF-kB-Luc plasmid. We are grateful
to JE Lee, HS Choi, JE Yu and SB Kwon for assistance with the
experiments.
Author Contributions
Conceived and designed the experiments: K-HL K-HK BLS. Performed
the experiments: K-HL E-SP SHP. Analyzed the data: K-HL K-HK SIC
KR YKP SYK S-IY I-KS. Contributed reagents/materials/analysis tools:
HCL. Wrote the paper: K-HL K-HK BLS.
References
1. Branda M, Wands JR (2006) Signal transduction cascades and hepatitis B and C
related hepatocellular carcinoma. Hepatology 43: 891–902.
2. Kremsdorf D, Soussan P, Paterlini-Brechot P, Brechot C (2006) Hepatitis B
virus-related human carcinogenesis. Oncogene 25: 3823–3833.
3. Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus.
J Virol 78: 12725–12734.
4. Tang H, Oishi N, Kaneko S, Murakami S (2006) Molecular functions and
biological roles of hepatitis B virus X protein. Cancer Sci 97: 977–983.
5. Wang WL, London WT, Lega L, Feitelson MA (1991) HBxAg in the liver from
carrier patients with chronic hepatitis and cirrhosis. Hepatology 14: 29–37.
6. Benn J, Su F, Doria M, Schneider RJ (1996) Hepatitis B virus HBx protein
induces transcription factor AP-1 by activation of extracellular signal-regulated
and c-Jun N-terminal Mitogen-Activated Protein kinases. J Vriol 70: 4978–4985.
7. Karin M (2006) Nuclear factor-kappaB in cancer development and progression.
Nature 441: 431–436.
8. Lucito R, Schneider RJ (1992) Hepatitis B virus protein activates transcription
factor NF-kB without requirement for protein kinase C. J Virol 66: 983–991.
9. Wang T, Wang Y, Wu MC, Guan XY, Yin ZF (2004) Activating mechanism of
transcriptor NF-kappaB regulated by hepatitis B virus X protein in
hepatocellular carcinoma. World J Gastroenterol 10: 356–360.
10. Waris G, Huh KW, Siddiqui A (2001) Mitochondrially associated hepatitis B
virus X protein constitutively activates transcription factors STAT-3 and NF-
kappa B via oxidative stress. Mol Cell Biol 21: 7721–7730.
11. Yun C, Um HR, Jin YH, Wang JH, Lee MO, et al. (2002) NF-kappaB activation
by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival.
Cancer Lett 184: 97–104.
12. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, et al. (2002)
Comparison of gene expression profiles between hepatitis B virus- and Hepatitis
C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on
the basis of a supervised learning method. Cancer Res 62: 3939–3944.
13. Kim MY, Park E, Park JH, Park DH, Moon WS, et al. (2001) Expression profile
of nine novel genes differentially expressed in hepatitis B virus-associated
hepatocellular carcinomas. Oncogene 20: 4568–4575.
14. Kim JH, You KR, Kim IH, Cho BH, Kim CY, et al. (2004) Over-expression of
the ribosomal protein L36a gene is associated with cellular proliferation in
hepatocellular carcinoma. Hepatology 39: 129–138.
15. Takagi M, Absalon MJ, McLure KG, Kastan MB (2005) Regulation of p53
translation and induction after DNA damage by ribosomal protein L26 and
Nucleodin. Cell 123: 49–53.
16. Lutsch G, Stahl J, Ka ¨rgel HJ, Noll F, Bielka H (1990) Immunoelectron
microscopic studies on the location of ribosomal proteins on the surface of the
40S ribosomal subunit from rat liver. Eur J Cell Biol 51: 140–150.
17. Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, et al. (2005) Epstein-Barr
virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
Exp Cell Res 303: 47–55.
18. Kho CJ, Wang Y, Zarbl H (1996) Effect of decreased fte-1 gene expression on
protein synthesis, cell growth, and transformation. Cell Growth Differ 7:
1157–1166.
19. Kho CJ, Zarbl H (1992) Fte-1,av-fos transformation effector gene, encodes the
mammalian homologue of a yeast gene involved in protein import into
mitochondria. Proc Natl Acad Sci U S A 89: 2200–2204.
20. Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, et al. (2000) Enhanced
expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer
Res 20: 2489–2494.
21. Musholt TJ, Goodfellow PJ, Scheumann GF, Pichlmayr R, Wells SA, Jr., et al.
(1997) Differential display in primary and metastatic medullary thyroid
carcinoma. J Surg Res 69: 94–100.
22. Pogue-geile K, Geiser JR, Shu M, Miller C, Wool IG, et al. (1991) Ribosomal
protein Genes are overexpressed in colorectal cancer: isolation of a cDNA clone
encoding the human S3 ribosomal protein. Mol Cell Biol 11: 3842–3849.
23. Slizhikova DK, Vinogradova TV, Sverdlov ED (2005) The NOLA2 and RPS3A
genes as highly informative markers for human squamous cell lung cancer.
Bioorg Khim 31: 195–199.
24. Starkey CR, Levy LS (1995) Identification of differentially expressed genes in
T-lymphoid malignancies in an animal model system. Int J Cancer 62:
325–331.
25. Tarantul VZ, Nikolaev AI, Martynenko A, Hannig H, Hunsmann G, et al.
(2000) Differential gene expression in B-cell non-Hodgkin’s lymphoma of SIV-
infected monkey. AIDS Res Hum Retroviruses 16: 173–179.
26. Naora H (1999) Involvement of ribosomal proteins in regulating cell growth and
apoptosis: translational modulation or recruitment for extraribosomal activity?
Immunol Cell Biol 77: 197–205.
Figure 8. RPS3a enhances HBx-induced NF-kB signaling via its chaperoning function in the context of a replication-competent HBV
genome. (A) RPS3a enhances the HBx-induced NF-kB activity in HBV full genome context. NF-kB activity was determined after co-transfection of the
replication-competent wild-type HBV 1.3mer or HBx-deficient HBV 1.3mer(X-) with pcD-RPS3a-flag and pNF-kB-Luc in Huh7 cells. (B) Effect of
endogenous RPS3a on HBV-mediated NF-kB activation. NF-kB activity was measured at 30 hr post co-transfection of wild type HBV1.3mer and pNF-
kB-Luc with/without the indicated siRNAs in Huh7 cells. (C–D) Effect of over-expression and knock-down of RPS3a on genome-driven viral proteins.
Cells were co-transfected as indicated in Figure 8A and 8B and harvested after 48 hr post-transfection. Western blot was performed using the whole
cell lysate (WCL). Note that HBx protein was only detected in cells transfected with WT HBV1.3mer. The expression levels of HBV proteins (HBs and
core protein) were constant under the over-expression or knock-down of RPS3a. L, M and S represent large, middle and small surface antigens,
respectively. (E) RPS3a increases the soluble expression of genome-driven HBx. Huh7 Cells were co-transfected with WT HBV 1.3mer and pcD-RPS3a-
flag and harvested at 48 hr post-transfection. Whole cell lysates (WCL) and soluble fractions (supernatant of WCL after centrifugation) were analyzed
by western blot by using indicated antibodies (left). HBx-HA was used as positive control for the specificity of anti-HBx antibody. HepG2.2.15 cells
were transfected with pcD-RPS3a-flag and harvested at 48 hr post-transfection. WCL and soluble fractions are analyzed by western blot (right).
doi:10.1371/journal.pone.0022258.g008
RPS3a Enhances HBx-Mediated NF-kB Signaling
PLoS ONE | www.plosone.org 16 August 2011 | Volume 6 | Issue 8 | e2225827. Naora H, Takai I, Adachi M, Naora H (1998) Altered cellular responses by
varying expression of a ribosomal protein gene: sequential coordination of
enhancement and suppression of ribosomal protein S3a gene expression induces
apoptosis. J Cell Biol 141: 741–753.
28. Naora H, Nishida T, Shindo Y, Adachi M, Naora H (1996) Constitutuvely
enhanced nbl expression is associated with the induction of internucleosomal
DNA cleavage by Actinomycin D. Biochem Biophys Res Commun 224:
258–264.
29. Song D, Sakamoto S, Taniguchi T (2002) Inhibition of Poly(ADP-ribose)
polymerase activity by Bcl-2 in association with the ribosomal protein S3a.
Biochemistry 41: 929–934.
30. Cui K, Coutts M, Stahl J, Sytkowski AJ (2000) Novel interaction between the
transcription factor chop(GADD153) and the ribosomal protein FTE/S3a
modulates erythropoiesis. J Biol Chem 275: 7591–7596.
31. Henkler F, Hoare J, Waseem N, Goldin RD, McGarvey MJ, et al. (2001)
Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 82:
871–882.
32. Kim KH, Seong BL (2003) Pro-apoptotic function of HBV X protein is
mediated by interaction with c-FLIP and enhancement of death-inducing signal.
EMBO J 22: 2104–2116.
33. Song CZ, Bai ZL, Song CC, Wang QW (2003) Aggregate formation of hepatitis
B virus X protein affects cell cycle and apoptosis. World J Gastroenterol 9:
1521–1524.
34. Urban S, Hildt E, Eckerskorn C, Sirma H, Kekule A, et al. (1997) Isolation and
molecular characterization of hepatitis B virsus X-protein from a baculovirus
expression system. Hepatology 26: 1045–1053.
35. Jameel S, Siddiqui A, Maguire HF, Rao KV (1990) Hepatitis B virus X protein
produced in Escherichia coli is biologically functional. J Virol 64: 3963–3966.
36. Liu D, Zou L, Li W, Wang L, Wu Y (2009) High-level expression and large-scale
preparation of soluble HBx antigen from Escherichia coli. Biotechnol Appl
Biochem 54: 141–147.
37. Marczinovits I, Somogyi C, Patthy A, Nemeth P, Molnar J (1997) An alternative
purification protocol for producing hepatitis B Virus X antigen on a preparative
scale in Escherichia coli. J Biotechnol 56: 81–88.
38. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock
proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:
164–172.
39. Tsutsumi S, Neckers L (2007) Extracellular heat shock protein 90: A role for a
molecule chaperone in cell motility and cancer metstasis. Cancer Sci 98:
1536–1539.
40. Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat
Rev Cancer 5: 761–772.
41. Kovacs D, Rakacs M, Agoston B, Lenkey K, Semrad K, et al. (2009) Janus
chaperones: Assistance of both RNA- and protein-folding by ribosomal proteins.
FEBS Lett 583: 88–92.
42. Kabir MA, Sherman F (2008) Overexpressed ribosomal proteins suppress
defective chaperonins in Saccharomyces cerevisiae. FEMS Yeast Res 8: 1236–1244.
43. Choi SI, Ryu K, Seong BL (2009) RNA-mediated chaperone type for de novo
protein folding. RNA Biol 6: 21–24.
44. Kim HK, Choi SI, Seong BL (2010) 5S rRNA-assisted DnaK refolding.
Biochem Biophys Res Commun 391: 1177–1181.
45. Choi SI, Han KS, Kim CW, Ryu K, Kim BH, et al. (2008) Protein solubility and
folding enhancement by interaction with RNA. PLoS One 3: e2677.
46. Kim CW, Han KS, Ryu KS, Kim BH, Kim KH, et al. (2007) N-terminal
domains of native multidomain proteins have the potential to assist de novo
folding of their downstream domains in vivo by acting as solubility enhancers.
Protein Sci 16: 635–643.
47. Trepel J, Mollapour M, Giaccone G, Neckers L (2010) Targeting the dynamic
HSP90 compelex in cancer. Nat Rev Cancer 10: 537–549.
RPS3a Enhances HBx-Mediated NF-kB Signaling
PLoS ONE | www.plosone.org 17 August 2011 | Volume 6 | Issue 8 | e22258